BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19172900)

  • 1. [Avian influenza vaccines].
    Vasil'ev IuM
    Vopr Virusol; 2008; 53(6):4-15. PubMed ID: 19172900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses.
    Wang T; Wei F; Liu J
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influenza vaccines adjuvants--contemporary state].
    Vasil'ev IuM
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (1):100-10. PubMed ID: 20218354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.
    Zheng D; Yi Y; Chen Z
    Viruses; 2012 Dec; 4(12):3589-605. PubMed ID: 23223214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of different chemical adjuvants on an avian influenza H6 DNA vaccine in chickens.
    Shan S; Fenwick S; Ellis T; Poinern E; Edwards J; Le X; Jiang Z
    Avian Pathol; 2016 Dec; 45(6):649-656. PubMed ID: 27314157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Influenza Congress Europe 2009.
    Silman NJ
    Expert Rev Vaccines; 2010 Mar; 9(3):273-5. PubMed ID: 20218855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race is on for flu vaccine.
    Wadman M
    Nature; 2005 Nov; 438(7064):23. PubMed ID: 16267526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Using reverse genetics method for developing recombinant strains of influenza viruses acceptable for use as live attenuated vaccines].
    Merkulov VA; Lebedev VN; Plekhanova TM; Maksimov VA; Korovkin SA; Mironov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):111-7. PubMed ID: 19462520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of vaccine strains of H5 and H7 influenza viruses.
    Soda K; Sakoda Y; Isoda N; Kajihara M; Haraguchi Y; Shibuya H; Yoshida H; Sasaki T; Sakamoto R; Saijo K; Hagiwara J; Kida H
    Jpn J Vet Res; 2008 Jan; 55(2-3):93-8. PubMed ID: 18318111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bird flu (avian influenza): applicable recombinant DNA techniques in research and vaccine development].
    Peeters B
    Tijdschr Diergeneeskd; 2008 Nov; 133(22):956-8. PubMed ID: 19058742
    [No Abstract]   [Full Text] [Related]  

  • 15. Avian influenza virus vaccines containing Toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens.
    St Paul M; Brisbin JT; Barjesteh N; Villaneueva AI; Parvizi P; Read LR; Nagy E; Sharif S
    Viral Immunol; 2014 May; 27(4):160-6. PubMed ID: 24797722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
    Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing live attenuated avian influenza virus in ovo vaccines for poultry.
    Wang L; Yassine H; Saif YM; Lee CW
    Avian Dis; 2010 Mar; 54(1 Suppl):297-301. PubMed ID: 20521649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
    Rudenko L; Isakova-Sivak I
    Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold-adapted influenza viruses as a promising platform for viral-vector vaccines.
    Isakova-Sivak I; Tretiak T; Rudenko L
    Expert Rev Vaccines; 2016 Oct; 15(10):1241-3. PubMed ID: 27385419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.